BAUGHMAN, R. P.; JUDSON, M.; CULVER, D.; BIRRING, S.; PARAMBIL, J.; ZEIGLER, J.; LOWER, E. E. Roflumilast (Daliresp®) to reduce acute pulmonary events in fibrotic sarcoidosis: a multi-center, double blind, placebo controlled, randomized clinical trial. Sarcoidosis, Vasculitis and Diffuse Lung Disease, [S. l.], v. 38, n. 3, p. e2021035, 2021. DOI: 10.36141/svdld.v38i3.11684. Disponível em: Acesso em: 27 nov. 2021.